Đang chuẩn bị liên kết để tải về tài liệu:
Outcomes of total hip arthroplasty in patients with primary immune thrombocytopenia

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Immune thrombocytopenia (ITP) is an immune-mediated acquired disease that is characterized by a decrease in the platelet count and an increased risk of bleeding. There is little information in the literature about the results of major joint replacement surgery in patients with ITP. |

TÀI LIỆU LIÊN QUAN

Complications to 6 months following total hip or knee arthroplasty: Observations from an Australian clinical outcomes registry

Preoperative opioid use is associated with worse patient outcomes after Total joint arthroplasty: A systematic review and meta-analysis

Multi-parametric muscle and fat correlation of computed tomography parameters to outcomes in a total hip arthroplasty population

Favourable clinical outcomes following cemented arthroplasty after metal-on-metal total hip replacement: A retrospective study with a mean follow-up of 10 years

Clinical, functional and radiographic outcomes of primary total hip arthroplasty between direct anterior approach and posterior approach: A systematic review and meta-analysis

Patient-reported outcomes following primary total hip arthroplasty in Crowe type III or IV developmental dysplasia are comparable to those in Crowe type I: A case-control study of 96 hips with intermediate-term follow-up

Do pessimists report worse outcomes after total hip arthroplasty

Does the addition of hip strengthening exercises improve outcomes following total knee arthroplasty? A study protocol for a randomized trial

Clinical and radiographic outcomes of a trabecular titanium™ acetabular component in hip arthroplasty: Results at minimum 5 years follow-up

Outcomes of total hip arthroplasty in patients with primary immune thrombocytopenia